← Back to Search

Platelet Rich Plasma

Autologous Platelet-Rich Plasma for Prostate Cancer

N/A

Waitlist Available

Led By Matthew T Gettman, M.D.

Research Sponsored by Matthew Gettman

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 18 months

Awards & highlights

Study Summary

This trial is testing whether platelets from a person's own blood can help nerve bundles heal after surgery.

Eligible Conditions

Prostate Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in complete blood count (CBC)

Number of subjects experiencing adverse events through 18 months

Secondary outcome measures

Change in Urological Function using the Expanded Prostate Cancer Index composite (EPIC)

Change in sexual function using International Index of Erectile Function (IIEF-5)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Platelet Rich Plasma (PRP) TreatmentExperimental Treatment2 Interventions

Platelets that are collected from the subject during the radical prostatectomy, for prostate cancer. The Autologous Platelet-Rich Plasma is concentrated in a device (Angel Concentrated Platelet Rich Plasma System) to 1,000,000 platelets/mL and applied topically once to the neurovascular bundle during the surgery.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Angel Concentrated Platelet Rich Plasma System

2016

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Matthew GettmanLead Sponsor

Matthew T Gettman, M.D.Principal InvestigatorMayo Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for individuals to enroll in this trial at present?

"Clinicaltrials.gov reveals that this particular medical study is not accepting enrollees at the moment, despite being initially posted on December 1st 2016 and recently updated in September 18th 2022. Despite this trial's unavailability, 1322 other trials are now open for enrollment."

Answered by AI

Is the patient population for this investigation limited to individuals aged 20 and above?

"Candidates that meet the qualifications for this experiment must be aged between 50 and 60. There are 76 studies catering to individuals younger than 18, while 1316 trials are designed specifically with senior citizens in mind."

Answered by AI

Is it plausible for me to participate in this research?

"This medical investigation is seeking 24 people in the 50-60 year age bracket with a diagnosed case of prostate cancer. Other requirements include having an active intimate partner."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Platelet Rich Plasma During Radical Prostatectomy

Matthew Gettman 2016. "Platelet Rich Plasma During Radical Prostatectomy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02957149.